Instrument Inactif

Autres langues CuraGen Corporation

Actions

Cours en clôture Nasdaq
- ^USD	-

31/07/09	CURAGEN CO USD0.01 : CuraGen Reports Second Quarter 2009 Financial Results
30/11/-1	CURAGEN : Reports Third Quarter 2008 Financial Results
30/11/-1	CURAGEN : to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
30/11/-1	CURAGEN : Corporation Receives Notification from NASDAQ
30/11/-1	CURAGEN : Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
30/11/-1	CURAGEN : to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
30/11/-1	CURAGEN : Corporation Regains NASDAQ Listing Compliance
30/11/-1	Curagen : CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million
30/11/-1	Curagen : CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million
30/11/-1	Curagen : CuraGen Reports First Quarter 2008 Financial Results
30/11/-1	Curagen : CuraGen Sells Ownership of Belinostat to TopoTarget A/S
30/11/-1	Curagen : CuraGen to Present at the BIO CEO & Investor Conference
30/11/-1	Curagen : CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
30/11/-1	CURAGEN : Announces Board of Director Changes
30/11/-1	CURAGEN : CuraGen's Board of Directors to Evaluate Strategic Initiatives
30/11/-1	CURAGEN : Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
30/11/-1	CURAGEN : to Present at the Rodman & Renshaw Annual Global Investment Conference